Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments

VIN-CENT WUSHUO-MENG WANGKUO-HOW HUANGTsai, Yao ChouYao ChouTsaiCHIEH-KAI CHANSHAO-YU YANGLIAN-YU LINCHIN-CHEN CHANGCHING-CHU LUYEN-HUNG LINYUNG-MING CHENSHIH-CHIEH CHUEH2023-04-172023-04-172022-020804-4643https://scholars.lib.ntu.edu.tw/handle/123456789/630233Long-term outcomes (especially mortality and/or major cardiovascular events (MACE)) of the unilateral primary aldosteronism (uPA) patients who underwent medical or surgery-targeted treatment, relative to those with essential hypertension (EH), have been scarcely reported.enTREATED PRIMARY ALDOSTERONISMTAIWAN SOCIETYoutcomesadrenalectomyhypertensionmanagementdiagnosisconsensusriskLong-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatmentsjournal article10.1530/EJE-21-0836348518592-s2.0-85122903788WOS:000758214800008